(BIOA-B) BioArctic (publ) - Performance -18.5% in 12m
Compare BIOA-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
47.76%
#10 in Group
Rel. Strength
30.65%
#5548 in Universe
Total Return 12m
-18.50%
#54 in Group
Total Return 5y
130.69%
#17 in Group
P/E -
(?) Percentile in Group
P/E Forward 12.3
48th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.10%
(?) Percentile in Group
12m Total Return: BIOA-B (-18.5%) vs XBI (-12.1%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: BIOA-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BIOA-B
Total Return (including Dividends) | BIOA-B | XBI | S&P 500 |
---|---|---|---|
1 Month | -20.68% | -14.90% | -7.04% |
3 Months | -18.02% | -14.51% | -10.88% |
12 Months | -18.50% | -12.11% | 5.72% |
5 Years | 130.69% | -20.56% | 100.77% |
Trend Score (consistency of price movement) | BIOA-B | XBI | S&P 500 |
1 Month | -88.5% | -85.2% | -76.1% |
3 Months | -64.1% | -87.6% | -86.4% |
12 Months | -8.30% | -24% | 67.8% |
5 Years | 68.5% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #119 | -6.79% | -14.7% |
3 Month | #77 | -4.10% | -8.0% |
12 Month | #55 | -7.27% | -22.9% |
5 Years | #17 | 190% | 14.9% |
FAQs
Does BIOA-B BioArctic (publ) outperforms the market?
No,
over the last 12 months BIOA-B made -18.50%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months BIOA-B made -18.02%, while XBI made -14.51%.
Over the last 3 months BIOA-B made -18.02%, while XBI made -14.51%.
Performance Comparison BIOA-B vs Indeces and Sectors
BIOA-B vs. Indices BIOA-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 11.4% | -13.6% | 17.7% | -24.2% |
US NASDAQ 100 | QQQ | 11.8% | -12.8% | 17.8% | -22.2% |
US Dow Jones Industrial 30 | DIA | 9.45% | -15.5% | 15.7% | -25.2% |
German DAX 40 | DAX | -1.15% | -12.6% | -0.87% | -37.8% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.35% | -12.9% | 12.9% | -26.5% |
Hongkong Hang Seng | HSI | 3.68% | -9.53% | 16.3% | -34.6% |
India NIFTY 50 | INDA | 7.34% | -24.1% | 18.3% | -19.2% |
Brasil Bovespa | EWZ | 6.84% | -14.4% | 17.4% | -7.57% |
BIOA-B vs. Sectors BIOA-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 11.5% | -13.1% | 9.51% | -31.8% |
Consumer Discretionary | XLY | 12.9% | -14.5% | 15.5% | -25.8% |
Consumer Staples | XLP | 6.09% | -20.6% | 10.1% | -31.0% |
Energy | XLE | 10.4% | -8.76% | 18.8% | -5.70% |
Financial | XLF | 8.64% | -15.8% | 9.79% | -37.9% |
Health Care | XLV | 8.94% | -13.9% | 18.9% | -18.4% |
Industrial | XLI | 8.85% | -14.7% | 18.3% | -22.4% |
Materials | XLB | 7.85% | -13.2% | 25.1% | -10.6% |
Real Estate | XLRE | 5.60% | -15.7% | 18.0% | -32.9% |
Technology | XLK | 12.0% | -10.9% | 23.7% | -15.3% |
Utilities | XLU | 5.83% | -18.6% | 13.5% | -44.9% |
Aerospace & Defense | XAR | 6.69% | -20.1% | 8.30% | -41.7% |
Biotech | XBI | 6.83% | -5.78% | 33.6% | -6.39% |
Homebuilder | XHB | 12.0% | -11.5% | 37.1% | -6.81% |
Retail | XRT | 11.6% | -14.9% | 25.0% | -11.5% |